Login to Your Account


Extension 10 times the original deal

Biogen Inc. didn't have to look far beyond the revenue stream for its spinal muscular atrophy (SMA) blockbuster, Spinraza (nusinersen), to conclude that keeping partner Ionis Pharmaceuticals Inc. close at hand was in its best interest. 

more »


Our Habitat for All Things Science
GWAS in Chinese population implicates immune system in Alzheimer's disease

A study has identified common genetic variants in the Chinese population contributing to the risk of developing Alzheimer's disease (AD) that possibly exert functional effects through the immune system, which could have important implications for AD management.

The search continues for promising biomarkers and effective disease-modifying therapies for AD. The current drug development approaches mainly target the disease's hallmark pathology of amyloid-beta (Abeta) protein accumulation in the brain leading to Abeta plaque deposition.

READ MORE »

Opinion


Partners in Focus